Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

Modeling Survival Data: Extending the Cox Model

2000 • 7,620 citations

Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*

1995 • 4,419 citations

Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease

1996 • 3,608 citations

Insulin-like growth factors and their binding proteins: biological actions

1995 • 1,976 citations

Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General Population

1993 • 1,783 citations

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

2004 • 1,669 citations

Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

1996 • 1,248 citations

The SU.VI.MAX Study

2004 • 929 citations

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1998 • 923 citations

Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trial

1998 • 682 citations

Study of Prediagnostic Selenium Level in Toenails and the Risk of Advanced Prostate Cancer

1998 • 554 citations

Association Between alpha-Tocopherol, gamma-Tocopherol, Selenium, and Subsequent Prostate Cancer

2000 • 406 citations

Design of Physicians' Health Study II—A Randomized Trial of Beta-Carotene, Vitamins E and C, and Multivitamins, in Prevention of Cancer, Cardiovascular Disease, and Eye Disease, and Review of Results of Completed Trials

2000 • 389 citations

A Primary Prevention Trial Using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers in a General Population

1998 • 361 citations

Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer

2000 • 220 citations

A Prospective Study of Plasma Selenium Levels and Prostate Cancer Risk

2004 • 215 citations

Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer

2004 • 198 citations

Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging

2001 • 186 citations

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

2000 • 157 citations

The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.

1998 • 153 citations

Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.

2003 • 149 citations

Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994

1995 • 148 citations

The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.

2003 • 147 citations

?-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma

1999 • 127 citations

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

2003 • 124 citations

Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: Seventeen-year follow-up of the prospective Basel study

1999 • 87 citations

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.

2001 • 81 citations

Prostate cancer prevention trials in the USA

2000 • 67 citations

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

2001 • 66 citations

Reference ranges for serum prostate-specific antigen in black and white men without cancer

1998 • 51 citations

Circulating Free Insulin-Like Growth Factor (IGF)-I , Total IGF-I, and IGF Binding Protein-3 Levels Do Not Predict the Future Risk to Develop Prostate Cancer: Results of a Case-Control Study Involving 201 Patients within a Population-Based Screening with a 4-Year Interval

2004 • 42 citations

Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay

1993 • 32 citations

Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 ?g/L: Are they useful tools for early detection and screening of prostate cancer?

2001 • 28 citations

Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials

2001 • 14 citations

Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer

2003 • 6 citations